モンタナ州における卵巣がんの臨床試験
モンタナ州内の拠点で、卵巣がんに関する10件の研究が参加者を募集しています。
モンタナ州内の都市
公式研究テキスト（英語）
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Bozeman Health Deaconess Hospital, Bozeman
- 他3件
被験者募集中第2相
全年齢 · 全性別 · 2026/10/02更新 · NCT05564377Torvutatug Samrotecan Plus Bevacizumab as First-line Maintenance in Homologous Recombination Deficiency (HRD) Negative Advanced Epithelial Ovarian Cancer
- Research Site, Billings
被験者募集中第3相
18歳以上 · 女性 · 2026/10/01更新 · NCT07851025A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
- Intermountain Health - Intermountain Health West End Clinic /ID# 278470, Billings
被験者募集中第2相
18歳以上 · 女性 · 2026/09/22更新 · NCT07059845A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- St. Vincent Regional Hospital - West End Clinic, Billings
被験者募集中第2相
18歳〜99歳 · 女性 · 2026/09/15更新 · NCT07023627Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- Billings Clinic, Billings
被験者募集中第3相
18歳以上 · 女性 · 2026/09/15更新 · NCT07214779A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- Billings Clinic Cancer Center, Billings
- Saint Vincent Healthcare, Billings
- Saint Vincent Frontier Cancer Center, Billings
- 他4件
被験者募集中
35歳〜50歳 · 女性 · 2026/08/07更新 · NCT04251052Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Community Hospital of Anaconda, Anaconda
- Billings Clinic Cancer Center, Billings
- Saint Vincent Healthcare, Billings
- 他11件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/07更新 · NCT06580314Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- St. Vincent Gynecologic Oncology, Billings
被験者募集中第3相
18歳以上 · 女性 · 2026/07/02更新 · NCT06819007Integrated Cancer Repository for Cancer Research
- Bozeman Health Deaconess Hospital, Bozeman
被験者募集中観察研究健康なボランティア歓迎
19歳〜110歳 · 全性別 · 2026/06/29更新 · NCT02012699SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Billings
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。